Todd is Chief Scientist at Intuitive Quantitation, LLC. Todd has extensive experience in building developmental stage neuroscience companies of all sizes as they advance products into patient trials. He has a 25-year track record of success in drug development and scientific leadership. Todd led neurology drug discovery at Bristol Myers Squibb and has worked as head of research, for multiple venture-backed start-ups. He has served as the Chief Scientific Officer for a software-based diagnostic company, conducted scientific due diligence for prominent investment firms, and contributed to a NASDAQ IPO as Chief Scientific Officer. In these roles, Todd’s work has advanced numerous pipeline products from preclinical development to initial human trials, including Phase 2 proof-of-concept studies. When he can find spare time, Todd enjoys taking long walks in the Minnesota woods.